论文部分内容阅读
目前减低剂量预处理异基因造血干细胞移植在治疗弥漫性大B细胞淋巴瘤(diffuse large B-cell lympho-ma,DLBCL)中的作用尚不清楚,相关文献报道较少。英国皇家自由医院和伦敦大学医学院研究小组对一组48例复发或耐药的DLBCL患者进行减低剂量预处理移植(reduced-intensity transpl
At present, the role of dose-reduced allogeneic hematopoietic stem cell transplantation in the treatment of diffuse large B-cell lympho-ma (DLBCL) remains unclear, and few reports have been reported. Royal Liberty Hospital and the University of London School of Medicine study group 48 patients with relapsed or resistant DLBCL patients underwent dose-reduced transplants (reduced-intensity transpl